This work is licensed under the Creative Commons Attribution 4.0 International License.
B. Ibanez et al., “2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation,” Eur. Heart J., vol. 39, no. 2, pp. 119–177, 2018, doi: 10.1093/eurheartj/ehx393.IbanezB.“2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation,”39211917710.1093/eurheartj/ehx393Open DOISearch in Google Scholar
B. Gorenek et al., “Cardiac arrhythmias in acute coronary syndromes: Position paper from the joint EHRA, ACCA, and EAPCI task force,” Europace, 2014, doi: 10.1093/europace/euu208.GorenekB.“Cardiac arrhythmias in acute coronary syndromes: Position paper from the joint EHRA, ACCA, and EAPCI task force,”201410.1093/europace/euu208Open DOISearch in Google Scholar
J. Schmitt, G. Duray, B. J. Gersh, and S. H. Hohnloser, “Atrial fibrillation in acute myocardial infarction: A systematic review of the incidence, clinical features and prognostic implications,” European Heart Journal. 2009, doi: 10.1093/eurheartj/ehn579.SchmittJ.DurayG.GershB. J.HohnloserS. H.“Atrial fibrillation in acute myocardial infarction: A systematic review of the incidence, clinical features and prognostic implications,”200910.1093/eurheartj/ehn579Open DOISearch in Google Scholar
B. S. Crenshaw, S. R. Ward, C. B. Granger, A. L. Stebbins, E. J. Topol, and R. M. Califf, “Atrial fibrillation in the setting of acute myocardial infarction: The GUSTO-I experience,” J. Am. Coll. Cardiol., vol. 30, no. 2, pp. 406–413, 1997, doi: 10.1016/S0735-1097(97)00194-0.CrenshawB. S.WardS. R.GrangerC. B.StebbinsA. L.TopolE. J.CaliffR. M.“Atrial fibrillation in the setting of acute myocardial infarction: The GUSTO-I experience,”30240641310.1016/S0735-1097(97)00194-0Open DOISearch in Google Scholar
S. R. Lee, E. K. Choi, K. Han, M. J. Cha, and S. Oh, “Prevalence of non-valvular atrial fibrillation based on geographical distribution and socioeconomic status in the entire Korean population,” Korean Circ. J., vol. 48, no. 7, pp. 622–634, 2018, doi: 10.4070/kcj.2017.0362.LeeS. R.ChoiE. K.HanK.ChaM. J.OhS.“Prevalence of non-valvular atrial fibrillation based on geographical distribution and socioeconomic status in the entire Korean population,”48762263410.4070/kcj.2017.0362Open DOISearch in Google Scholar
tefania Matei et al., “The Relationship Between Psychosocial Status and Hypertensive Condition.,” Curr. Hypertens. Rep., vol. 20, no. 12, p. 102, Oct. 2018, doi: 10.1007/s11906-018-0902-y.Mateitefania“The Relationship Between Psychosocial Status and Hypertensive Condition.,”2012102Oct.201810.1007/s11906-018-0902-yOpen DOISearch in Google Scholar
E. G. Daoud et al., “Effect of an irregular ventricular rhythm on cardiac output,” Am. J. Cardiol., 1996, doi: 10.1016/S0002-9149(97)89297-1.DaoudE. G.“Effect of an irregular ventricular rhythm on cardiac output,”199610.1016/S0002-9149(97)89297-1Open DOISearch in Google Scholar
J. P. Piccini and L. A. Allen, “Heart Failure Complicated by Atrial Fibrillation: Don’t Bury the Beta-Blockers Just Yet,” JACC: Heart Failure. 2017, doi: 10.1016/j.jchf.2016.12.003.PicciniJ. P.AllenL. A.“Heart Failure Complicated by Atrial Fibrillation: Don’t Bury the Beta-Blockers Just Yet,”201710.1016/j.jchf.2016.12.003Open DOISearch in Google Scholar
B. Gorenek and G. Kudaiberdieva, “Atrial Fibrillation in Acute St-Elevation Myocardial Infarction: Clinical and Prognostic Features,” Curr. Cardiol. Rev., 2012, doi: 10.2174/157340312803760857.GorenekB.KudaiberdievaG.“Atrial Fibrillation in Acute St-Elevation Myocardial Infarction: Clinical and Prognostic Features,”201210.2174/157340312803760857Open DOISearch in Google Scholar
Ş. Çelik, C. Erdöl, M. Baykan, Ş. Kaplan, and H. Kasap, “Relation between paroxysmal atrial fibrillation and left ventricular diastolic function in patients with acute myocardial infarction,” Am. J. Cardiol., 2001, doi: 10.1016/S0002-9149(01)01611-3.ÇelikŞ.ErdölC.BaykanM.KaplanŞ.KasapH.“Relation between paroxysmal atrial fibrillation and left ventricular diastolic function in patients with acute myocardial infarction,”200110.1016/S0002-9149(01)01611-3Open DOISearch in Google Scholar
G. Hindricks et al., “2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS),” Eur. Heart J., 2020, doi: 10.1093/eurheartj/ehaa612.HindricksG.“2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS),”202010.1093/eurheartj/ehaa612Open DOISearch in Google Scholar
Z. Kalarus et al., “Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: An European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and ,” Europace, 2019, doi: 10.1093/europace/euz163.KalarusZ.“Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: An European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and ,”201910.1093/europace/euz163Open DOISearch in Google Scholar
C. T. January et al., “2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation,” J. Am. Coll. Cardiol., 2019, doi: 10.1016/j.jacc.2019.01.011.JanuaryC. T.“2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation,”201910.1016/j.jacc.2019.01.011Open DOISearch in Google Scholar
J. B. Segal et al., “The evidence regarding the drugs used for ventricular rate control,” Journal of Family Practice. 2000.SegalJ. B.“The evidence regarding the drugs used for ventricular rate control,”2000Search in Google Scholar
M. Metawee et al., “Digoxin and short term mortality after acute STEMI: Results from the MAGIC trial,” Int. J. Cardiol., 2016, doi: 10.1016/j.ijcard.2016.05.022.MetaweeM.“Digoxin and short term mortality after acute STEMI: Results from the MAGIC trial,”201610.1016/j.ijcard.2016.05.022Open DOISearch in Google Scholar
S. P. Thomas et al., “Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial,” Am. Heart J., 2004, doi: 10.1016/s0002-8703(03)00526-x.ThomasS. P.“Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial,”200410.1016/s0002-8703(03)00526-xOpen DOISearch in Google Scholar
R. D. Lopes et al., “Digoxin and Mortality in Patients With Atrial Fibrillation,” J. Am. Coll. Cardiol., 2018, doi: 10.1016/j.jacc.2017.12.060.LopesR. D.“Digoxin and Mortality in Patients With Atrial Fibrillation,”201810.1016/j.jacc.2017.12.06029519345Open DOISearch in Google Scholar
J.-P. Collet et al., “2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation,” Eur. Heart J., pp. 1–79, 2020, doi: 10.1093/eurheartj/ehaa575.ColletJ.-P.“2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation,”179202010.1093/eurheartj/ehaa57532860058Open DOISearch in Google Scholar
K. Saraf, P. Morris, P. Garg, P. Sheridan, and R. Storey, “Non-Vitamin K antagonist oral anticoagulants (NOACs): Clinical evidence and therapeutic considerations,” Postgrad. Med. J., vol. 90, no. 1067, pp. 520–528, 2014, doi: 10.1136/postgradmedj-2014-132605.SarafK.MorrisP.GargP.SheridanP.StoreyR.“Non-Vitamin K antagonist oral anticoagulants (NOACs): Clinical evidence and therapeutic considerations,”90106752052810.1136/postgradmedj-2014-13260525085900Open DOISearch in Google Scholar
C. P. Cannon et al., “Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation,” N. Engl. J. Med., 2017, doi: 10.1056/nejmoa1708454.CannonC. P.“Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation,”201710.1056/nejmoa1708454Open DOISearch in Google Scholar
C. M. Gibson et al., “Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI,” N. Engl. J. Med., 2016, doi: 10.1056/nejmoa1611594.GibsonC. M.“Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI,”201610.1056/nejmoa1611594Open DOISearch in Google Scholar
R. D. Lopes et al., “Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation,” N. Engl. J. Med., 2019, doi: 10.1056/nejmoa1817083.LopesR. D.“Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation,”201910.1056/nejmoa1817083Open DOISearch in Google Scholar
P. Vranckx et al., “Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial,” Eur. Heart J., 2020, doi: 10.1093/eurheartj/ehaa617.VranckxP.“Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial,”202010.1093/eurheartj/ehaa617776763532860041Open DOISearch in Google Scholar
F. J. Neumann et al., “2018 ESC/EACTS Guidelines on myocardial revascularization,” European Heart Journal. 2019, doi: 10.1093/eurheartj/ehy394.NeumannF. J.“2018 ESC/EACTS Guidelines on myocardial revascularization,”201910.1093/eurheartj/ehy39430165437Open DOISearch in Google Scholar
M. Eldar et al., “Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era,” Circulation, 1998, doi: 10.1161/01.CIR.97.10.965.EldarM.“Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era,”199810.1161/01.CIR.97.10.965Open DOISearch in Google Scholar
O. D. Pedersen, H. Bagger, L. Køber, and C. Torp-Pedersen, “The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution.,” Eur. Heart J., 1999, doi: 10.1053/euhj.1998.1352.PedersenO. D.BaggerH.KøberL.Torp-PedersenC.“The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution.,”199910.1053/euhj.1998.135210329066Open DOISearch in Google Scholar
N. Danchin et al., “Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: Data from the FAST-MI register,” Heart, 2010, doi: 10.1136/hrt.2010.201574.DanchinN.“Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: Data from the FAST-MI register,”201010.1136/hrt.2010.20157420965993Open DOISearch in Google Scholar
R. D. Lopes et al., “Safety and Efficacy of Antithrombotic Strategies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials,” JAMA Cardiol., 2019, doi: 10.1001/jamacardio.2019.1880.LopesR. D.“Safety and Efficacy of Antithrombotic Strategies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials,”201910.1001/jamacardio.2019.1880658488531215979Open DOISearch in Google Scholar
D. E. Thomas, N. Jex, and A. R. Thornley, “Ventricular arrhythmias in acute coronary syndromes-mechanisms and management,” Contin. Cardiol. Educ., vol. 3, no. 1, pp. 22–29, 2017, doi: 10.1002/cce2.51.ThomasD. E.JexN.ThornleyA. R.“Ventricular arrhythmias in acute coronary syndromes-mechanisms and management,”31222910.1002/cce2.51Open DOISearch in Google Scholar
J. P. Piccini et al., “Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction,” Crit. Care Med., vol. 39, no. 1, pp. 78–83, 2011, doi: 10.1097/CCM.0b013e3181fd6ad7.PicciniJ. P.“Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction,”391788310.1097/CCM.0b013e3181fd6ad7301035220959785Open DOISearch in Google Scholar
M. J. Janse and A. L. Wit, “Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction,” Physiological Reviews. 1989, doi: 10.1152/physrev.1989.69.4.1049.JanseM. J.WitA. L.“Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction,”198910.1152/physrev.1989.69.4.10492678165Open DOISearch in Google Scholar
M. Said et al., “Calcium-calmodulin dependent protein kinase II (CaMKII): A main signal responsible for early reperfusion arrhythmias,” J. Mol. Cell. Cardiol., 2011, doi: 10.1016/j.yjmcc.2011.08.010.SaidM.“Calcium-calmodulin dependent protein kinase II (CaMKII): A main signal responsible for early reperfusion arrhythmias,”201110.1016/j.yjmcc.2011.08.010Open DOISearch in Google Scholar
J. M. Di Diego and C. Antzelevitch, “Ischemic ventricular arrhythmias: Experimental models and their clinical relevance,” Hear. Rhythm, 2011, doi: 10.1016/j.hrthm.2011.06.036.Di DiegoJ. M.AntzelevitchC.“Ischemic ventricular arrhythmias: Experimental models and their clinical relevance,”201110.1016/j.hrthm.2011.06.036Open DOISearch in Google Scholar
N. KH, T. T, Stebbins A, T. EJ, and Califf, “Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. Circulation nell’Infarto Miocardico (GISSI).,” Circulation, 1998.KHN.TT.StebbinsAEJT.Califf“Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. Circulation nell’Infarto Miocardico (GISSI).,”1998Search in Google Scholar
V. Barletta, I. Fabiani, C. Lorenzo, I. Nicastro, and V. Di Bello, “Sudden cardiac death: A review focused on cardiovascular imaging,” Journal of Cardiovascular Echography. 2014, doi: 10.4103/2211-4122.135611.BarlettaV.FabianiI.LorenzoC.NicastroI.Di BelloV.“Sudden cardiac death: A review focused on cardiovascular imaging,”201410.4103/2211-4122.135611Open DOISearch in Google Scholar
S. G. Priori et al., “2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the Europea,” Eur. Heart J., vol. 36, no. 41, pp. 2793–2867l, 2015, doi: 10.1093/eurheartj/ehv316.PrioriS. G.“2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the Europea,”364127932867l10.1093/eurheartj/ehv316Open DOISearch in Google Scholar
C. J. Nalliah, S. Zaman, A. Narayan, J. Sullivan, and P. Kovoor, “Coronary artery reperfusion for ST elevation myocardial infarction is associated with shorter cycle length ventricular tachycardia and fewer spontaneous arrhythmias,” Europace, 2014, doi: 10.1093/europace/eut307.NalliahC. J.ZamanS.NarayanA.SullivanJ.KovoorP.“Coronary artery reperfusion for ST elevation myocardial infarction is associated with shorter cycle length ventricular tachycardia and fewer spontaneous arrhythmias,”201410.1093/europace/eut307Open DOISearch in Google Scholar
A. Volpi, A. Cavalli, L. Santoro, and E. Negri, “Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction-results of the gruppo italiano per lo studio della sopravvivenza nell’infarto miocardico (GISSI-2) database,” Am. J. Cardiol., 1998, doi: 10.1016/s0002-9149(98)00336-1.VolpiA.CavalliA.SantoroL.NegriE.“Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction-results of the gruppo italiano per lo studio della sopravvivenza nell’infarto miocardico (GISSI-2) database,”199810.1016/s0002-9149(98)00336-1Open DOISearch in Google Scholar
X. Z. He, S. H. Zhou, X. H. Wan, H. Y. Wang, Q. H. Zhong, and J. F. Xue, “The effect of early and intensive statin therapy on ventricular premature beat or nonsustained ventricular tachycardia in patients with acute coronary syndrome,” Clin. Cardiol., 2011, doi: 10.1002/clc.20818.HeX. Z.ZhouS. H.WanX. H.WangH. Y.ZhongQ. H.XueJ. F.“The effect of early and intensive statin therapy on ventricular premature beat or nonsustained ventricular tachycardia in patients with acute coronary syndrome,”201110.1002/clc.20818665254421259280Open DOISearch in Google Scholar
R. Latini, A. P. Maggioni, M. Flather, P. Sleight, and G. Tognoni, “ACE inhibitor use in patients with myocardial infarction: Summary of evidence from clinical trials,” Circulation. 1995, doi: 10.1161/01.CIR.92.10.3132.LatiniR.MaggioniA. P.FlatherM.SleightP.TognoniG.“ACE inhibitor use in patients with myocardial infarction: Summary of evidence from clinical trials,”199510.1161/01.CIR.92.10.3132Open DOISearch in Google Scholar
J. S. Bundgaard et al., “Deep sedation as temporary bridge to definitive treatment of ventricular arrhythmia storm,” Eur. Hear. J. Acute Cardiovasc. Care, 2020, doi: 10.1177/2048872620903453.BundgaardJ. S.“Deep sedation as temporary bridge to definitive treatment of ventricular arrhythmia storm,”202010.1177/204887262090345332193944Open DOISearch in Google Scholar
J. Bhar-Amato, W. Davies, and S. Agarwal, “Ventricular arrhythmia after acute myocardial infarction: ‘The perfect storm,’” Arrhythmia Electrophysiol. Rev., vol. 6, no. 3, pp. 134–139, 2017, doi: 10.15420/aer.2017.24.1.Bhar-AmatoJ.DaviesW.AgarwalS.“Ventricular arrhythmia after acute myocardial infarction: ‘The perfect storm,’”6313413910.15420/aer.2017.24.1561073129018522Open DOISearch in Google Scholar
H. V. Huikuri, A. Castellanos, and R. J. Myerburg, “Sudden Death Due to Cardiac Arrhythmias,” N. Engl. J. Med., 2001, doi: 10.1056/nejmra000650.HuikuriH. V.CastellanosA.MyerburgR. J.“Sudden Death Due to Cardiac Arrhythmias,”200110.1056/nejmra000650Open DOISearch in Google Scholar
J. P. Piccini et al., “Relation of Mortality to Failure to Prescribe Beta Blockers Acutely in Patients With Sustained Ventricular Tachycardia and Ventricular Fibrillation Following Acute Myocardial Infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Re,” Am. J. Cardiol., vol. 102, no. 11, pp. 1427–1432, 2008, doi: 10.1016/j.amjcard.2008.07.033.PicciniJ. P.“Relation of Mortality to Failure to Prescribe Beta Blockers Acutely in Patients With Sustained Ventricular Tachycardia and Ventricular Fibrillation Following Acute Myocardial Infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Re,”102111427143210.1016/j.amjcard.2008.07.033Open DOISearch in Google Scholar
H. J. Dargie, “Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial,” Lancet, 2001, doi: 10.1016/S0140-6736(00)04560-8.DargieH. J.“Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial,”200110.1016/S0140-6736(00)04560-8Open DOISearch in Google Scholar
S. M. Al-Khatib et al., 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary, vol. 138, no. 13. 2018.Al-KhatibS. M.13813201810.1161/CIR.000000000000061530354427Search in Google Scholar
F. Mehraein, “A Review on Amiodarone as an Antiarrhythmic Drug,” Abnorm. Hear. Rhythm., 2015, doi: 10.5772/60418.MehraeinF.“A Review on Amiodarone as an Antiarrhythmic Drug,”201510.5772/60418Open DOISearch in Google Scholar
R. M. L. Colunga Biancatelli, V. Congedo, L. Calvosa, M. Ciacciarelli, A. Polidoro, and L. Iuliano, “Adverse reactions of amiodarone,” J. Geriatr. Cardiol., vol. 16, no. 7, pp. 552–566, 2019, doi: 10.11909/j.issn.1671-5411.2019.07.004.Colunga BiancatelliR. M. L.CongedoV.CalvosaL.CiacciarelliM.PolidoroA.IulianoL.“Adverse reactions of amiodarone,”16755256610.11909/j.issn.1671-5411.2019.07.004668951631447894Open DOISearch in Google Scholar